Replacing a phosphodiesterase-5 inhibitor with riociguat in patients with connective tissue disease-associated pulmonary arterial hypertension: a case series

Patients with pulmonary arterial hypertension associated with connective tissue disease (PAH-PAH-CTD) such as systemic sclerosis (SSc) have a poorer response to treatment and increased mortality compared with patients with idiopathic PAH. Current treatment options for PAH-CTD include prostanoids, ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Raina, Amresh, Benza, Raymond L., Farber, Harrison W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841890/
https://www.ncbi.nlm.nih.gov/pubmed/28671485
http://dx.doi.org/10.1177/2045893217721694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841890/
https://www.ncbi.nlm.nih.gov/pubmed/28671485
http://dx.doi.org/10.1177/2045893217721694

Ejemplares similares